「GSK3 inhibitor enhances gemtuzumab ozogamicin-induced apoptosis in primary human leukemia cells by overcoming multiple mechanisms of resistance」の関連論文
-
Study of the Effects of Inhibition of Epigenetic Regulators on the Proliferation of Hematological Malignant Tumor Cells
-
Characterization of the Anticancer Activities of Some Natural and Synthetic Compounds: Molecular Targets and Mechanism
-
Identification of the ultrahigh-risk subgroup in neuroblastoma cases through DNA methylation analysis and its treatment exploiting cancer metabolism
-
Design of Novel Targeted Co-delivery System for Combined Chemotherapy and Gene Therapy of Hepatocellular Carcinoma [an abstract of entire text]
-
Generation of molecular-targeting peptides for selective inhibition of the interaction between CTLA-4 and B7 in the dog: a new immune checkpoint inhibitor for cancer therapy
-
Lusutrombopag effectively promotes the growth and differentiation of megakaryocytic cells from patients with myelodysplastic syndrome
-
2-nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche (本文)
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Vaticanol C, a phytoalexin, induces apoptosis of leukemia and cancer cells by modulating expression of multiple sphingolipid metabolic enzymes
-
Efficacy of the Novel Tubulin Polymerization Inhibitor PTC-028 for Myelodysplastic Syndrome
-
A RUNX-targeted gene switch-off approach modulates the BIRC5/PIF1-p21 pathway and reduces glioblastoma growth in mice
-
Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
-
Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
-
Study on the regulation of CD8+ T cell immune response through nuclear receptor RORα and REV-ERB [an abstract of entire text]
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Complex roles of the actin-binding protein Girdin/GIV in DNA damage-induced apoptosis of cancer cells
-
Metformin Inhibits Proliferation and Tumor Growth of QGP-1 Pancreatic Neuroendocrine Tumor Cells by Inducing Cell Cycle Arrest and Apoptosis
-
CDK8/19 inhibition plays an important role in pancreatic β-cell induction from human iPSCs
-
Genome-scale CRISPR/Cas9 screening for gemcitabine modulators in pancreatic cancer
-
MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells
-
Nrf2/p-Fyn/ABCB1 axis accompanied by p-Fyn nuclear accumulation plays pivotal roles in vinorelbine resistance in non-small cell lung cancer
-
Characterization of cisplatin effects in lenvatinib‐resistant hepatocellular carcinoma cells
-
Activation of BAX and BAK is an attractive combination therapy in melanoma
-
肺がん細胞の senolysis とferroptosis において 細胞質 p21Cip1/Waf1 は防御的に作用する
-
The role of vagus nerve stimulation through acetylcholine receptor during atherosclerosis progression
-
Circulatory C-type natriuretic peptide reduces mucopolysaccharidosis-associated craniofacial hypoplasia in vivo
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells
-
Mammalian methionine adenosyltransferase 2A promotes rRNA processing and methylation of translation factors to induce translation in an mTORC1-independent manner
-
Efficacious Combination Drug Treatment for Colorectal Cancer that Overcomes Resistance to KRAS G12C Inhibitors
-
Studies on the Enhancement of Antitumor Effect by Drug Combination in Molecular-Targeted Therapy of Cancer
-
Studies on the pathological mechanism of alopecia areata in C3H/HeJ mouse model
-
A study on the immunostimulatory effects of alarmin HMGN1 in cancer immunity
-
シグナル伝達抗体(Signalobody)を用いた細胞の運命制御系の開発
-
Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma.
-
In situ vaccination using unique TLR9 ligand K3-SPG induces long-lasting systemic immune response and synergizes with systemic and local immunotherapy
-
Finding potential synergistic drugs to reduce chemo-resistance for the treatment of highly malignant tumors in female
-
Chemosensitivity of Patient-Derived Cancer Stem Cells Identifies Colorectal Cancer Patients with Potential Benefit from FGFR Inhibitor Therapy
-
Identification of calcium and integrin-binding protein 1 (CIB1) as a novel regulator of production of Amyloid β peptide using CRISPR/Cas9-based screening system
-
Effects of Senkyunolide I on ischemic cell injury and neurogenesis
-
Suppression of malignant rhabdoid tumors through Chb-M′-mediated RUNX1 inhibition
-
Mechanisms by which Bacterial and Viral Pathogens cause Ovarian dysfunction
-
Elucidation of Hair Growth and Hair Pigmentation Promotion Effect of 3,4,5-Tri-O-Caffeoylquinic Acid
-
JNK and Yorkie drive tumor malignancy by inducing L-amino acid transporter 1 in Drosophila
-
Design and Functional Evaluation of Drug Delivery System Based on Dendritic Molecules and Gold Nanorods
-
Design and In vivo Evaluation of Novel mRNA Lipid Nanoparticles Beyond the Hepatocytes Towards a New Era of Personalized Gene Therapies [an abstract of entire text]
-
Genetic and chemical inhibition of IRF5 suppresses pre-existing mouse lupus-like disease
-
Oncolytic HSV-1 in combination with lenalidomide for plasma cell neoplasms
-
Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease